ImmuPharma (LON:IMM) Trading 7.5% Higher – What’s Next?

ImmuPharma plc (LON:IMM) rose 7.5% during mid-day trading on Monday . The company traded as high as GBX 1.32 ($0.02) and last traded at GBX 1.32 ($0.02). Approximately 1,167,245 shares changed hands during trading, a decline of 34% from the average daily volume of 1,776,601 shares. The stock had previously closed at GBX 1.23 ($0.02).

ImmuPharma Trading Up 1.7 %

The company has a market capitalization of £5.15 million, a PE ratio of -123.00 and a beta of 1.53. The stock has a fifty day simple moving average of GBX 1.71 and a 200-day simple moving average of GBX 1.84.

About ImmuPharma

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.